Clarity Pharmaceuticals Ltd
Status: Publicly traded
Direct answer
Clarity Pharmaceuticals Ltd is publicly traded on ASX under the ticker CU6.AX.
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to...
Can you invest in Clarity Pharmaceuticals Ltd?
Yes. Clarity Pharmaceuticals Ltd is publicly traded on ASX under the ticker CU6.AX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Clarity Pharmaceuticals Ltd
Detailed equity research is provided by MarketSnap.